UAA Stock Analysis: Under Armour | NYSE
Apparel Manufacturing | NYSE, USA | Market Cap: 2.827m USD | 12M Return: -4.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 48.6M
EPS Trend: -76.1%
Qual. Beats: 0
Rev. Trend: -98.7%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Under Armour, Inc. (UAA) is a U.S.-based performance apparel, footwear, and accessories company that designs, develops, markets, and distributes products for men, women, and youth across compression, fitted, and loose-fit categories. Its product range spans running, training, basketball, outdoor, and casual footwear, alongside accessories such as gloves, bags, headwear, and socks, sold under brand names including UNDER ARMOUR, HEATGEAR, COLDGEAR, HOVR, and ARMOUR FLEECE. The company operates a hybrid distribution model combining wholesale channels (sporting goods chains, specialty retailers, department stores, and team/institutional sales) with direct-to-consumer outlets, including mono-brand retail stores, factory house locations, and e-commerce websites. Founded in 1996 and headquartered in Baltimore, Maryland, Under Armour sells internationally across North America, Europe, the Middle East, Africa, Asia-Pacific, and Latin America, and is classified within the Consumer Discretionary sectors Apparel, Accessories & Luxury Goods sub-industry. As a mid-cap stock in a highly competitive global athletic and athleisure market, the company competes with larger peers such as Nike and Adidas, where brand strength, product innovation, and the balance between wholesale and DTC channels are key drivers of margin performance and long-term growth.
- North American wholesale revenue decline pressures top line
- Inventory cleanup and promotions weigh on gross margins
- DTC and international growth offsets wholesale softness
| Net Income: -495.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.04 > 0.02 and ΔFCF/TA 1.63 > 1.0 |
| NWC/Revenue: 20.90% < 20% (prev 23.62%; Δ -2.71% < -1%) |
| CFO/TA -0.02 > 3% & CFO -75.1m > Net Income -495.6m |
| Net Debt (2.38b) to EBITDA (376.2m): 6.33 < 3 |
| Current Ratio: 1.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (426.0m) vs 12m ago -0.77% < -2% |
| Gross Margin: 45.86% > 18% (prev 47.88%; Δ -2.02% > 0.5%) |
| Asset Turnover: 114.4% > 50% (prev 120.1%; Δ -5.74% > 0%) |
| Interest Coverage Ratio: 8.81 > 6 (EBIT TTM 266.5m / Interest Expense TTM 30.3m) |
| A: 0.24 (Total Current Assets 2.72b - Total Current Liabilities 1.68b) / Total Assets 4.42b |
| B: 0.05 (Retained Earnings 217.4m / Total Assets 4.42b) |
| C: 0.06 (EBIT TTM 266.5m / Avg Total Assets 4.36b) |
| D: 0.47 (Book Value of Equity 1.41b / Total Liabilities 3.00b) |
| Altman-Z'' = 2.61 = A |
| DSRI: 1.05 (Receivables 681.9m/675.8m, Revenue 4.98b/5.17b) |
| GMI: 1.04 (GM 47.88% / 45.86%) |
| AQI: 0.69 (AQ_t 0.15 / AQ_t-1 0.22) |
| SGI: 0.96 (Revenue 4.98b / 5.17b) |
| TATA: -0.10 (NI -495.6m - CFO -75.1m) / TA 4.42b) |
| Beneish M = -3.17 (Cap -4..+1) = AA |
As of July 11, 2026, the stock is trading at USD 6.59 with a total of 5,136,015 shares traded. Over the past week, the price has changed by +0.15%, over one month by +14.01%, over three months by +5.10% and over the past year by -4.91%.
Current recommended Stop Loss: 5.70 (which is 13.5% or 2.9 ATR below the current price).
Under Armour has received a consensus analysts rating of 3.23. Therefore, it is recommended to hold UAA.
- StrongBuy: 5
- Buy: 1
- Hold: 17
- Sell: 1
- StrongSell: 2
| Analysts Target Price | 6.3 | -4.7% |
P/E Forward = 60.241
P/S = 0.5691
P/B = 1.9985
P/EG = 1.8363
Revenue TTM = 4.98b USD
EBIT TTM = 266.5m USD
EBITDA TTM = 376.2m USD
Long Term Debt = 590.6m USD (from longTermDebt, last quarter)
Short Term Debt = 752.9m USD (from shortTermDebt, last quarter)
Debt = 2.69b USD (from shortLongTermDebtTotal, last quarter) + Leases 749.2m
Net Debt = 2.38b USD (calculated: Debt 2.69b - CCE 309.2m)
Enterprise Value = 5.21b USD (2.83b + Debt 2.69b - CCE 309.2m)
Interest Coverage Ratio = 8.81 (Ebit TTM 266.5m / Interest Expense TTM 30.3m)
EV/FCF = -32.10x (Enterprise Value 5.21b / FCF TTM -162.2m)
FCF Yield = -3.11% (FCF TTM -162.2m / Enterprise Value 5.21b)
FCF Margin = -3.25% (FCF TTM -162.2m / Revenue TTM 4.98b)
Net Margin = -9.94% (Net Income TTM -495.6m / Revenue TTM 4.98b)
Gross Margin = 45.86% ((Revenue TTM 4.98b - Cost of Revenue TTM 2.70b) / Revenue TTM)
Gross Margin QoQ = 42.01% (prev 44.71%)
Tobins Q-Ratio = 1.18 (Enterprise Value 5.21b / Total Assets 4.42b)
Interest Expense / Debt = 1.13% (Interest Expense 30.3m / Debt 2.69b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 210.6m (EBIT 266.5m * (1 - 21.00%))
Current Ratio = 1.62 (Total Current Assets 2.72b / Total Current Liabilities 1.68b)
Debt / Equity = 1.90 (Debt 2.69b / totalStockholderEquity, last quarter 1.41b)
Debt / EBITDA = 6.33 (Net Debt 2.38b / EBITDA 376.2m)
Debt / FCF = -14.67 (negative FCF - burning cash) (Net Debt 2.38b / FCF TTM -162.2m)
Total Stockholder Equity = 1.64b (last 4 quarters mean from totalStockholderEquity)
RoA = -11.37% (Net Income -495.6m / Total Assets 4.42b)
RoE = -30.13% (Net Income TTM -495.6m / Total Stockholder Equity 1.64b)
RoCE = 11.92% (EBIT 266.5m / Capital Employed (Equity 1.64b + L.T.Debt 590.6m))
RoIC = 6.49% (NOPAT 210.6m / Invested Capital 3.24b)
WACC = 6.08% (E(2.83b)/V(5.52b) * Re(11.02%) + D(2.69b)/V(5.52b) * Rd(1.13%) * (1-Tc(0.21)))
Discount Rate = 11.02% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -82.22 | Cagr: -2.26%
[DCF] Fair Price = unknown (Cash Flow -162.2m)
EPS Correlation: -76.14 | EPS CAGR: -61.83% | SUE: -0.14 | # QB: 0
Revenue Correlation: -98.75 | Revenue CAGR: -6.60% | SUE: 0.23 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.02 | Chg30d=N/A | Revisions=+7% | Analysts=18
EPS next Quarter (2026-09-30): EPS=0.06 | Chg30d=-50.42% | Revisions=-71% | Analysts=19
EPS current Year (2027-03-31): EPS=0.11 | Chg30d=+0.37% | Revisions=-87% | GrowthEPS=-9.7% | GrowthRev=-0.6%
EPS next Year (2028-03-31): EPS=0.24 | Chg30d=-2.56% | Revisions=-40% | GrowthEPS=+117.9% | GrowthRev=+2.9%
[Analyst] Revisions Ratio: -66% (up=7, down=40)